PharmaDrug becomes first company to receive Orphan Drug Designation for DMT from the US FDA
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) announced that it has received Orphan Drug Designation for its dimethyltryptamine (DMT) formulation to prevent ischemia-reperfusion injury from organ transplantation from the US Food and Drug Administration (FDA).
The designation was granted to PharmaDrug’s subsidiary Sairiyo Therapeutics Inc and covers solid organ transplantation, which includes the liver, kidney, heart and lungs.
According to Toronto-based PharmaDrug, the orphan drug designation is broader than its original application, which was for kidney transplantation only.
READ: PharmaDrug signs deal to begin manufacturing potential esophageal cancer and coronavirus treatment Cepharanthine
PharmaDrug told shareholders that the FDA’s decision to broaden the designation recognizes the “pernicious consequences” of ischemia-reperfusion injury (IRI) in all solid organ transplantation.
Daniel Cohen, PharmaDrug’s CEO, told investors that the company is the only company in the world that has received orphan drug designation for DMT.
“We are incredibly pleased to have reached this significant milestone as it validates our strategy in discovering novel uses, formulations and delivery methods for DMT while also securing market exclusivity and patent protection of DMT for rare diseases,” Cohen said in a statement.
Cohen added that the company is building on the achievement by positioning its research initiatives to evaluate DMT in potential human clinical studies for these types of serious and life-threatening indications.
The company is currently evaluating specific DMT formulations aimed at superior delivery and improved efficacy. Its management will contemplate additional pre-clinical research in inflammatory and oxidative stress-induced complications, including organ transplants, to better understand the role DMT plays in the field.
PharmaDrug is focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/947939/pharmadrug-becomes-first-company-to-receive-orphan-drug-designation-for-dmt-from-the-us-fda-947939.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).